Exchange Traded Concepts’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Buy |
65,132
+2,706
| +4% | +$80K | 0.02% | 480 |
|
|
2025
Q1 | $1.86M | Sell |
62,426
-12,669
| -17% | -$378K | 0.03% | 388 |
|
|
2024
Q4 | $2.15M | Buy |
75,095
+3,402
| +5% | +$97.5K | 0.04% | 353 |
|
|
2024
Q3 | $2.77M | Buy |
71,693
+5,469
| +8% | +$211K | 0.06% | 249 |
|
|
2024
Q2 | $2.13M | Buy |
66,224
+3,695
| +6% | +$119K | 0.05% | 278 |
|
|
2024
Q1 | $2.43M | Buy |
+62,529
| New | +$2.43M | 0.06% | 264 |
|
|
2023
Q1 | – | Sell |
-77,435
| Closed | -$1.8M | – | 1165 |
|
|
2022
Q4 | $1.8M | Buy |
77,435
+2,364
| +3% | +$54.8K | 0.05% | 196 |
|
|
2022
Q3 | $1.2M | Sell |
75,071
-1,402
| -2% | -$22.5K | 0.04% | 228 |
|
|
2022
Q2 | $1.36M | Buy |
76,473
+2,278
| +3% | +$40.4K | 0.04% | 235 |
|
|
2022
Q1 | $1.51M | Buy |
74,195
+50,785
| +217% | +$1.03M | 0.03% | 256 |
|
|
2021
Q4 | $437K | Buy |
23,410
+423
| +2% | +$7.9K | 0.01% | 712 |
|
|
2021
Q3 | $454K | Buy |
+22,987
| New | +$454K | 0.01% | 658 |
|